8-K - Aardvark Therapeutics, Inc. (0001774857) (Filer)
Published . Updated .
8-K - Aardvark Therapeutics filed an 8-K with the SEC on Oct 23 (a notice of a material company event).
Directly affected
- AARD Aardvark Therapeutics-16.4%
Named in this report.
Indirectly affected
- No related companies are mapped for this report yet.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| AARD | -4.07% | -1.27% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-23 AccNo: 0001193125-26-429509 Size: 11 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
The price since 23 Oct 2026: Aardvark Therapeutics (AARD) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| Aardvark Therapeutics (AARD) | three days earlier | -1.27% | final price |
| Aardvark Therapeutics (AARD) | five days earlier | -4.07% | final price |
| GLD | three days earlier | +2.33% | final price |
| GLD | five days earlier | +3.51% | final price |
| QQQ | three days earlier | +1.80% | final price |
| QQQ | five days earlier | +0.75% | final price |
| SPY | three days earlier | +0.66% | final price |
| SPY | five days earlier | -0.09% | final price |
| TLT | three days earlier | -1.97% | final price |
| TLT | five days earlier | -2.07% | final price |
Who gains and who loses around Aardvark Therapeutics (AARD)
Companies mentioned with this story
- AARD Aardvark Therapeutics
Aardvark Therapeutics (AARD) is linked, with no stored direction, high confidence in the 23 Oct 2026 story “8-K - Aardvark Therapeutics, Inc. (0001774857) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> AARD
How “8-K - Aardvark Therapeutics, Inc. (0001774857) (Filer)” reaches Aardvark Therapeutics (AARD)
Aardvark Therapeutics (AARD) is the company in “8-K - Aardvark Therapeutics, Inc. (0001774857) (Filer),” the 23 Oct 2026 this story story.
For Aardvark Therapeutics (AARD), the reason on file says SEC 8-K filing -> direct issuer disclosure -> AARD
The price range for Aardvark Therapeutics (AARD), and the dates in the story
AARD traded between 3.67 and 5.84 across 15 sessions. The latest close on file is 4.45.
What the saved facts support for Aardvark Therapeutics (AARD)
14 out of 100
“8-K - Aardvark Therapeutics, Inc. (0001774857) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.